Similarly, a knock-in mouse model of CHCHD2 p.T61I mutation showed accelerated mortality, progressive motor deficits, dopaminergic neurons loss with age, accompanied by the neuropathological feature of PD, accumulation and aggregation of αSyn and pSyn in the brains. This evidence concerns the gene CHCHD2 and Parkinson disease.